This is bad news.
This was posted on Facebook:
Dr. Stanislaw Burzynski’s Four Year Battle with the Texas Medical Board Ends. Case Dismissed!
On November 19, 2012, judges of the Texas State Office of Administrative Hearings dismissed the Texas Medical Board’s pending case against Dr. Burzynski. The investigation started by the board in 2008 involved Dr. Burzynski’s novel off-label use of combination gene targeted therapy. Early on, two medical board informal settlement panels found that the use of these combination drugs on the advanced cancer patients involved was within the standard of care. However, the Texas Medical Board refused to drop the case and instead filed a formal complaint against Dr. Burzynski alleging the same standard of care violations previously rejected by the board settlement panels. After two years of intense litigation, the case was set for trial in April 2012. However, a week before trial, the administrative law judges dismissed most of the charges against Dr. Burzynski which forced the Board to seek to adjourn the case to do some reevaluation. After the judges denied the Board’s attempt to reverse the previous partial dismissal of the case, the Board did more reevaluation and moved to dismiss the entire case. The attorney representing Dr. Burzynski, Mr. Richard Jaffe, didn’t oppose the motion and on November 19, 2012, the case was dismissed.
The cutting-edge, multi-agent gene targeted therapy devised by Dr. Burzynski which was at the heart of this proceeding continues to be given at the clinic and is helping countless patients. The Burzynski Clinic thanks all of its many supporters and wishes all a Happy Thanksgiving.
Here is the official dismissal.
Does it mean his trouble are over? No.
Does it mean his therapy is validated? No.
It allows him to continue to operate his clinic and doing what he has been doing.
Updates to follow…